Myopia
Conditions
Brief summary
To compare the preventive effects of daily low-level red-light and 0.01% low-dose atropine eye drops on myopia.
Interventions
DEVICElow-level red-light
650-nm low-level red-light
DRUGAtropine (0.01%)
Atropine eye drops at concentration of 0.01%
Sponsors
Beijing Tongren Hospital
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
7 Years to 18 Years
Healthy volunteers
Yes
Inclusion criteria
* 1\. Aged at least 7 years old. 2. The spherical equivalent error (SER) after pupil dilation was between -0.5 D and +0.75D. 3\. Had a record of cycloplegia SER at least 6 months before this study, and SER changed -0.5D compared with the last measurement or had a family history of high myopia. 4\. Corneal astigmatism ≤ 1.25D. 5. Interocular refraction discrepancy ≤ 1.5D. 6. No allergy history of cycloplegia drugs. 7. Willingness to participate in the study and signed informed consent.
Exclusion criteria
\- 1. Intraocular pressure was below 10 mm Hg or higher than 22 mm Hg. 2. Presence of amblyopia, or ocular pathological conditions such as retinal, lens, or corneal disorders. 3\. Children currently using other myopia interventions other than LDA or LLRL. 4. Children with systemic and immune disorders, such as albinism, psoriasis, nephrotic syndrome, systemic lupus erythematosus, and diabetes 5. Individuals with conditions like Tourette's syndrome or epilepsy.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of myopia | 12 months | 12-month incidence of myopia |
Countries
China
Outcome results
None listed